Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 787 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR Researchers at Purdue Create Filler That May Help Regenerate Tissue in... March 9, 2021 New tool to tackle gaps in public’s knowledge of blood cancer... July 14, 2023 OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally... August 4, 2025 Zucchini everywhere October 9, 2020 Load more HOT NEWS NCI’s Rare Cancer Clinics: Engaging Patients and Fostering Collaboration 6 Things to Know About Regrowing and Caring for Your Hair... NHL Player Carey Price Surprises 11-Year-Old Boy Who Just Lost Mom... 2022 ASCO Annual Meeting: Advances in Treating Breast Cancer, Colorectal Cancer, Ewing...
